Stem Cell Market Research Reports & Industry Analysis
Cells must meet very specific criteria in order to be termed stem cells. They must: produce copies themselves; proliferate at a rapid rate; and display certain proteins on their surface that indicate a capacity to differentiate into other tissues, such as bone and cartilage. A stem cell line is a group of cells that all descend from a single original stem cell. Symmetric division gives rise to two identical daughter cells both endowed with stem cell properties. Asymmetric division produces only one stem cell and a progenitor cell with limited self-renewal potential.
Stem Cell Industry Research & Market Reports
-
Umbilical Cord Blood Processing Products Market by Product (CD Markers, Cell Culture Devices, Cell Culture Reagents), End-Users (Private Banks, Public Banks) - Global Forecast 2024-2030
... at USD 1.53 billion in 2023 and expected to reach USD 1.69 billion in 2024, at a CAGR 10.93% to reach USD 3.16 billion by 2030. Global Umbilical Cord Blood Processing Products Market FPNV Positioning ... Read More
-
Microcarriers Market by Product (Consumables, Equipment), Application (Biologics Manufacturing, Cell Therapy, Vaccine Manufacturing), End User - Global Forecast 2024-2030
... USD 2.37 billion in 2024, at a CAGR 9.99% to reach USD 4.22 billion by 2030. Global Microcarriers MarketMicrocarriers are small spherical beads made from materials such as dextran, polystyrene, gelatin, or glass that provide ... Read More
-
North America Cell and Gene Therapy Manufacturing Services Market Forecast to 2030 - Regional Analysis - by Type [Cell Therapy (Autologous and Allogenic) and Gene Therapy (Viral and Non-Viral Vector)], Indication (Cancer, Orthopedics, and Others), Application (Clinical Manufacturing and Commercial Manufacturing), and End User [Pharmaceutical and Biotechnology Companies and Contract Research Organization (CROs)]
... Application (Clinical Manufacturing and Commercial Manufacturing), and End User [Pharmaceutical and Biotechnology Companies and Contract Research Organization (CROs)] The North America cell and gene therapy manufacturing services market is expected to grow from US$ 4,153.27 ... Read More
-
Autologous Stem Cell & Non-Stem Cell Based Therapies Market by Type (Autologous Non-Stem Cells, Autologous Stem Cells), Indication (Cancer, Cardiovascular Disease, Neurodegenerative Disorders), End-User - Global Forecast 2024-2030
... Based Therapies Market size was estimated at USD 7.17 billion in 2023 and expected to reach USD 8.22 billion in 2024, at a CAGR 14.78% to reach USD 18.83 billion by 2030. FPNV Positioning Matrix ... Read More
-
South & Central America Cell and Gene Therapy Manufacturing Services Market Forecast to 2030 - Regional Analysis - by Type [Cell Therapy (Autologous and Allogenic) and Gene Therapy (Viral and Non-Viral Vector)], Indication (Cancer, Orthopedics, and Others), Application (Clinical Manufacturing and Commercial Manufacturing), and End User [Pharmaceutical and Biotechnology Companies and Contract Research Organization (CROs)]
... and Others), Application (Clinical Manufacturing and Commercial Manufacturing), and End User [Pharmaceutical and Biotechnology Companies and Contract Research Organization (CROs)] The South & Central America cell and gene therapy manufacturing services market is expected to ... Read More
-
Lysosomal Storage Diseases Market by Disease Type (Fabry Diseases, Gaucher's Diseases, Mucopolysaccharidosis), Type of Therapy (Enzyme Replacement Therapy, Stem Cell Therapy, Substrate Reduction Therapy), End User - Global Forecast 2024-2030
... size was estimated at USD 9.31 billion in 2023 and expected to reach USD 9.98 billion in 2024, at a CAGR 7.48% to reach USD 15.43 billion by 2030. FPNV Positioning Matrix The FPNV Positioning ... Read More
-
Paroxysmal Nocturnal Hemoglobinuria Treatment Market by Diagnostic Test (Bone Marrow Examination, Complete Blood Count Test, Flow Cytometry), Treatment (Blood Transfusion, Medication, Stem Cell Transplant) - Global Forecast 2024-2030
... estimated at USD 87.89 billion in 2023 and expected to reach USD 103.05 billion in 2024, at a CAGR 17.35% to reach USD 269.37 billion by 2030. Global Partner Relationship Management Market FPNV Positioning Matrix ... Read More
-
Stem Cell Therapy Market by Type (Allogeneic Stem Cell Therapy, Autologous Stem Cell Therapy), Cell Source (Adipose Tissue-Derived MSCs, Bone Marrow-Derived MSCs, Placental / Umbilical Cord-Derived MSCs), Therapeutic Application, End-User - Global Forecas
... Stem Cell Therapy Market size was estimated at USD 439.83 million in 2023 and expected to reach USD 493.20 million in 2024, at a CAGR 12.88% to reach USD 1,027.29 million by 2030. Global Stem ... Read More
-
Cellular Immunotherapy Market by Type (CAR T-Cell Therapy, Dendritic Cell Therapy, NK Cell Therapy), Indication (B-Cell Malignancies, Liver Cancer, Prostate Cancer), Technology Type, End-Use - Global Forecast 2024-2030
... at USD 11.23 billion in 2023 and expected to reach USD 14.02 billion in 2024, at a CAGR 25.34% to reach USD 54.60 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal ... Read More
-
Amyotrophic Lateral Sclerosis Treatment Market by Treatment (Medication, Stem Cell Therapy), Distribution Channel (Hospital Pharmacies, Retail Pharmacies) - Global Forecast 2024-2030
... 2023 and expected to reach USD 790.52 million in 2024, at a CAGR 7.73% to reach USD 1,237.05 million by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the Amyotrophic Lateral ... Read More
-
Stem Cell Banking Market by Type (Cord Blood, Cord Tissue), Service (Analysis, Collection, Processing), Source, Application - Global Forecast 2024-2030
... expected to reach USD 16.98 billion in 2024, at a CAGR 17.22% to reach USD 44.24 billion by 2030. Global Stem Cell Banking Market FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating ... Read More
-
Hemoglobinopathies Market by Indication (Sickle Cell Disease, Thalassemia), Treatment (Blood Transfusion, Bone Marrow & Stem Cell Transplant, Chemotherapy), Diagnosis, End-User - Global Forecast 2024-2030
... 2023 and expected to reach USD 2.79 billion in 2024, at a CAGR 33.02% to reach USD 19.46 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the Hemoglobinopathies Market. ... Read More
-
Nerve Repair & Regeneration Market by Product (Biomaterials, Neurostimulation & Neuromodulation Devices), Application (Direct Nerve Repair/Neurorrhaphy, Nerve Grafting, Neurostimulation & Neuromodulation Surgeries), End-User - Global Forecast 2024-2030
... estimated at USD 10.10 billion in 2023 and expected to reach USD 11.43 billion in 2024, at a CAGR 13.27% to reach USD 24.18 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is ... Read More
-
Europe Cell and Gene Therapy Manufacturing Services Market Forecast to 2030 - Regional Analysis - by Type [Cell Therapy (Autologous and Allogenic) and Gene Therapy (Viral and Non-Viral Vector)], Indication (Cancer, Orthopedics, and Others), Application (Clinical Manufacturing and Commercial Manufacturing), and End User [Pharmaceutical and Biotechnology Companies and Contract Research Organization (CROs)]
... (Clinical Manufacturing and Commercial Manufacturing), and End User [Pharmaceutical and Biotechnology Companies and Contract Research Organization (CROs)] The Europe cell and gene therapy manufacturing services market is expected to grow from US$ 1,879.77 million in ... Read More
-
Middle East & Africa T Cell Therapy Market Forecast to 2030 - Regional Analysis - by Modality (Research and Commercialized), Therapy Type [CAR T-cell Therapy and T-cell Receptor (TCR)-based], and Indication (Hematologic Malignancies and Solid Tumors)
... Tumors) The Middle East & Africa T cell therapy market was valued at US$ 73.14 million in 2022 and is expected to reach US$ 211.46 million by 2030; it is estimated to grow at a ... Read More
-
Asia Pacific T Cell Therapy Market Forecast to 2030 - Regional Analysis - by Modality (Research and Commercialized), Therapy Type [CAR T-cell Therapy and T-cell Receptor (TCR)-based], and Indication (Hematologic Malignancies and Solid Tumors)
... Asia Pacific T cell therapy market was valued at US$ 251.99 million in 2022 and is expected to reach US$ 882.72 million by 2030; it is estimated to grow at a CAGR of 17.0% from ... Read More
-
Apoptosis Market by Product Type (Assays, Instrument, Reagents), Technique (Cell Imaging & Analysis Systems, Flow Cytometry, Spectrophotometry), Application, End-user - Global Forecast 2024-2030
... and expected to reach USD 5.72 billion in 2024, at a CAGR 7.50% to reach USD 8.88 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the Apoptosis Market. It ... Read More
-
Hunter Syndrome Treatment Market by Treatment (Enzyme Replacement Therapy, Hematopoietic Stem Cell Transplant), End User (Clinics, Home Healthcare, Hospitals) - Global Forecast 2024-2030
... in 2023 and expected to reach USD 1.17 billion in 2024, at a CAGR 8.06% to reach USD 1.87 billion by 2030. Global Hunter Syndrome Treatment Market FPNV Positioning Matrix The FPNV Positioning Matrix is ... Read More
-
Human Embryonic Stem Cells Market by Type (Pluripotent Stem Cells, Totipotent Stem Cells, Unipotent Stem Cells), Application (Regenerative Medicine, Stem Cell Biology Research, Tissue Engineering), End-User - Global Forecast 2024-2030
... Market size was estimated at USD 848.35 million in 2023 and expected to reach USD 920.43 million in 2024, at a CAGR 8.98% to reach USD 1,549.81 million by 2030. Global Human Embryonic Stem Cells ... Read More
-
Automated & Closed Cell Therapy Processing Systems Market by Workflow (Apheresis, Cryopreservation, Expansion), Type (Non-Stem Cell Therapy, Stem Cell Therapy), Scale - Global Forecast 2024-2030
... was estimated at USD 943.94 million in 2023 and expected to reach USD 1,087.97 million in 2024, at a CAGR 15.74% to reach USD 2,626.76 million by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix ... Read More
-
Cell & Gene Therapy Biomanufacturing CDMO Market by Component (Cell Therapy, Plasmid DNA, Viral Vector), Phase (Phase 1, Phase 2, Phase 3), Indication - Global Forecast 2024-2030
... size was estimated at USD 338.12 million in 2023 and expected to reach USD 485.47 million in 2024, at a CAGR 32.53% to reach USD 2,428.90 million by 2030. FPNV Positioning Matrix The FPNV Positioning ... Read More
-
Neuroprotection Market by Product (Apoptosis Inhibitors, Free Anti-Inflammatory Agents, Glutamate Antagonists), Treatment (Alzheimer's Disease, Amyotrophic Lateral Sclerosis, Brain Injury), Application - Global Forecast 2024-2030
... 2023 and expected to reach USD 16.20 billion in 2024, at a CAGR 9.86% to reach USD 28.52 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the Neuroprotection Market. ... Read More
-
Europe T Cell Therapy Market Forecast to 2030 - Regional Analysis - by Modality (Research and Commercialized), Therapy Type [CAR T-cell Therapy and T-cell Receptor (TCR)-based], and Indication (Hematologic Malignancies and Solid Tumors)
... T cell therapy market was valued at US$ 699.24 million in 2022 and is expected to reach US$ 2,345.49 million by 2030; it is estimated to grow at a CAGR of 16.3% from 2022 to ... Read More
-
Umbilical Cord Blood Banking Market by Storage (Private Cord Blood Banks, Public Cord Blood Banks), Application (Bone Marrow Failure Syndrome, Immune Deficiencies, Leukemia) - Global Forecast 2024-2030
... estimated at USD 28.34 billion in 2023 and expected to reach USD 33.08 billion in 2024, at a CAGR 16.80% to reach USD 84.08 billion by 2030. Global Umbilical Cord Blood Banking Market FPNV Positioning ... Read More
-
Global Diabetes Stem Cell Therapy Market Growth (Status and Outlook) 2025-2031
... it is expected to grow at a CAGR of 61.6% from 2025 to 2031. North America key players of Diabetes Stem Cell Therapy include CellTrans, Seraxi, Vertex Pharmaceuticals, CRISPR Therapeutics, iTolerance, etc. The top five ... Read More
Research Assistance
